These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23966756)

  • 1. A case of graves' disease diagnosed in the course of bilateral carotid artery stenoses (moyamoya disease); a case report and review of the literature.
    Kamasaki H; Takeuchi T; Mikami T; Komeichi K; Tsutsumi H
    Clin Pediatr Endocrinol; 2013 Jul; 22(3):39-44. PubMed ID: 23966756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.
    Yamada H; Okajima F; Onda T; Fujimori S; Emoto N; Sugihara H
    BMC Endocr Disord; 2020 Aug; 20(1):132. PubMed ID: 32847555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two adolescent patients with coexistent Graves' disease and Moyamoya disease in Korea.
    Cheon CK; Kim SY; Yoo JH
    Korean J Pediatr; 2014 Jun; 57(6):287-91. PubMed ID: 25076974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
    Kubo T; Toki J; Kado Y; Kurihara M; Moriwake T; Kanzaki S; Seino Y
    Endocr J; 2000 Apr; 47(2):197-201. PubMed ID: 10943745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An infant case of Graves' disease with ophthalmopathy.
    Kubo T; Shimizu J; Furujo M; Takeuchi A; Yoshioka-Iwaso H; Eguchi N; Fukuhara S; Koyama T; Kanadani T; Shiraga H; Oshima K
    Endocr J; 2005 Oct; 52(5):647-50. PubMed ID: 16284447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya Syndrome: Differential Diagnosis in Patients With Central Nervous System Symptoms and Hyperthyroidism.
    Maezawa Y; Nagasaki K; Aiyama H; Yamamoto Y; Shibata Y
    Cureus; 2024 Feb; 16(2):e53519. PubMed ID: 38445131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease coexisted with resistance to thyroid hormone: a case report.
    Akahori H; Usuda R
    J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Asahi K; Hidaka Y; Tamaki H; Iwatani Y; Amino N
    Endocr J; 1995 Jun; 42(3):405-12. PubMed ID: 7670570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.